Sign in
4

Changes in Ownership

ELI LILLY & Co Filed Acc 0000059478-25-000030

EVP & Pres., Lilly Oncology gave up 1,409.84 shares (to pay taxes)

  • EVP & Pres., Lilly Oncology acquired 3,023 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Van Naarden Jacob · EVP & Pres., Lilly Oncology

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2025-02-01 Exercise or conversion : show line 1 in the form +3,023 14,868 D
2025-02-01 Shares withheld for taxes : show line 2 in the form −1,409.84 $811.08 $1,143,492 13,458.16 D

Table II: Derivative

1 line
Date Transaction Shares Expires Underlying Owned after D/I
2025-02-01 Exercise or conversion : show line 3 in the form Restricted Stock Unit −3,023 2025-02-01 3,023 0 D
Loading xslF345X05/wk-form4_1738704376.xml…